KIRATLI, H. Et Al. 2020. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma. JAPANESE JOURNAL OF OPHTHALMOLOGY , vol.64, no.4 , 351-358.

KIRATLI, H., KOÇ, İ., ÖZTÜRK, E., VARAN, A., & AKYÜZ, C., (2020). Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma. JAPANESE JOURNAL OF OPHTHALMOLOGY , vol.64, no.4, 351-358.

KIRATLI, HAYYAM Et Al. "Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma," JAPANESE JOURNAL OF OPHTHALMOLOGY , vol.64, no.4, 351-358, 2020

KIRATLI, HAYYAM Et Al. "Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma." JAPANESE JOURNAL OF OPHTHALMOLOGY , vol.64, no.4, pp.351-358, 2020

KIRATLI, H. Et Al. (2020) . "Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma." JAPANESE JOURNAL OF OPHTHALMOLOGY , vol.64, no.4, pp.351-358.

@article{article, author={HAYYAM KIRATLI Et Al. }, title={Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma}, journal={JAPANESE JOURNAL OF OPHTHALMOLOGY}, year=2020, pages={351-358} }